HMOs show direct positive health effects independent of the gut microbiome
20 Jun 2023 | Chr. Hansen
Yannik Schönknecht, a scientific advisor at Chr. Hansen, takes us through the latest Human Milk Oligosaccharides (HMOs) research and reveals what is coming up in this field. Schönknecht says that HMOs are prebiotic and have been shown to bring several health benefits independent of the gut microbiome. He predicts that improved technologies and production capabilities will drive the increased interest in the gut microbiome.
More videos
